Recent developments
AI summary of recent coverageRecent coverage has focused on Dr. Brad Diephuis's appointment as Chief Executive Officer of Thyme Care, with co-founder Robin Shah transitioning to Executive Chairman. The headlines also document the company's fundraising milestones and business developments, including a $97 million Series D round and partnerships with major health plans to expand value-based cancer care services.
Summarized from the headlines below; see each source for the full story.
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Dr. Brad Diephuis, it will appear here — and tie into the news timeline.
In the News
10 stories- citybiz·
Thyme Care Appoints Dr. Brad Diephuis CEO, Elevates Robin Shah to Executive Chairman
- PR Newswire·
Thyme Care Evolves Leadership: Dr. Brad Diephuis Named Chief Executive Officer, Co-Founder Robin Shah Appointed Executive Chairman to Launch New Business Lines
- hitconsultant.net·
Thyme Care Appoints Dr. Brad Diephuis as CEO, Co-Founder Robin Shah Appointed Executive Chairman
- MedCity News·
Thyme Care Banks $97M to Accelerate Value-Based Cancer Care
- PR Newswire·
$97M Series D Backed by Strategic Investors Across the Oncology Ecosystem Positions Thyme Care to Break Through Cancer Care's Biggest Bottlenecks
- MobiHealthNews·
Humana selects Thyme Care for oncology services
- Hospice News·
Thyme Care Secures ‘Milestone’ Investment from Echo, CVS Health Ventures
- Fierce Healthcare·
Industry Voices—Closer look at CMS reimbursement for navigation
- PR Newswire·
Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic
- MedCity News·
Heard at HLTH: What’s on Healthcare Executives’ Agenda for 2023?
Dr. Brad Diephuis: FAQ
- What company does Dr. Brad Diephuis lead?
- Dr. Brad Diephuis is CEO of Thyme Care.